Back to search
FDAFDA · Food and drugs·Recall number D-0235-2026

Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10

Published December 24, 2025 · Recall initiated: November 26, 2025

Summary

FDA records drug Class II recall D-0235-2026, published December 24, 2025 and initiated November 26, 2025. Recalling firm: Golden State Medical Supply Inc.; Status: Ongoing; Reported quantity: 2472 HDPE Bottles; Lot: Lot GS065762. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated · Letter

Get an email if BACLOFEN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BACLOFEN
Manufacturer
Golden State Medical Supply Inc.
Distributor
Nationwide within the USA
Lot
Lot GS065762
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10 recalled?

Yes. FDA published recall D-0235-2026 on December 24, 2025. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BACLOFEN.